| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |